339
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Severe Mental Illness Among Adults with Atopic Eczema or Psoriasis: Population-Based Matched Cohort Studies within UK Primary Care

ORCID Icon, , , , , , ORCID Icon, , , ORCID Icon, & ORCID Icon show all
Pages 363-374 | Received 15 Aug 2022, Accepted 23 Dec 2022, Published online: 17 Mar 2023

References

  • Kapur S, Watson W, Carr S. Atopic dermatitis. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):52. doi:10.1186/s13223-018-0281-6
  • World Health Organisation. Global report on psoriasis. Available from: https://apps.who.int/iris/bitstream/handle/10665/204417/9789241565189_eng.pdf.psoriasis?sequence=1. Accessed July 8, 2022.
  • Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(suppl 1):8–16. doi:10.1159/000370220
  • Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369. doi:10.1136/bmj.m1590
  • GOV.UK. Severe mental illness (SMI) and physical health inequalities: briefing. Available from: https://www.gov.uk/government/publications/severe-mental-illness-smi-physical-health-inequalities/severe-mental-illness-and-physical-health-inequalities-briefing. Accessed February 1, 2022.
  • Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014;13(2):153–160. doi:10.1002/wps.20128
  • Thyssen JP, Hamann CR, Linneberg A, et al. Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide. Allergy. 2018;73(1):214–220. doi:10.1111/all.13231
  • Nicholas MN, Gooderham MJ. Atopic dermatitis, depression, and suicidality. J Cutan Med Surg. 2017;21(3):237–242. doi:10.1177/1203475416685078
  • Koo J, Marangell LB, Nakamura M, et al. Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression. J Eur Acad Dermatol Venereol. 2017;31(12):1999–2009. doi:10.1111/jdv.14460
  • Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146(8):891–895. doi:10.1001/archdermatol.2010.186
  • Chen YH, Lee HC, Lin HC. Prevalence and risk of atopic disorders among schizophrenia patients: a nationwide population based study. Schizophr Res. 2009;108(1–3):191–196. doi:10.1016/j.schres.2008.12.021
  • Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135:984–991. doi:10.1038/jid.2014.530
  • Begemann MJH, Linszen MMJ, de Boer JN, et al. Atopy increases risk of psychotic experiences: a large population-based study. Front Psychiatry. 2019;10:453. doi:10.3389/fpsyt.2019.00453
  • Schmitt J, Romanos M, Pfennig A, Leopold K, Meurer M. Psychiatric comorbidity in adult eczema. Br J Dermatol. 2009;161(4):878–883. doi:10.1111/j.1365-2133.2009.09309.x
  • Eaton WW, Byrne M, Ewald H, et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006;163(3):521–528. doi:10.1176/appi.ajp.163.3.521
  • Chen SJ, Chao YL, Chen CY, et al. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br J Psychiatry. 2012;200(5):374–380. doi:10.1192/bjp.bp.111.092098
  • Gabilondo A, Alonso-Moran E, Nuño-Solinis R, Orueta JF, Iruin A. Comorbidities with chronic physical conditions and gender profiles of illness in schizophrenia. Results from PREST, a new health dataset. J Psychosom Res. 2017;93:102–109. doi:10.1016/j.jpsychores.2016.12.011
  • Yin X, Wineinger NE, Wang K, et al. Common susceptibility variants are shared between schizophrenia and psoriasis in the Han Chinese population. J Psychiatry Neurosci. 2016;41:413. doi:10.1503/jpn.150210
  • Waters F, Chiu V, Atkinson A, Blom JD. Severe sleep deprivation causes hallucinations and a gradual progression toward psychosis with increasing time awake. Front Psychiatry. 2018;10(9):303. doi:10.3389/fpsyt.2018.00303
  • Silverberg JI, Greenland P. Eczema and cardiovascular risk factors in 2 US adult population studies. J Allergy Clin Immunol. 2015;135:721–728.e6. doi:10.1016/j.jaci.2014.11.023
  • Brenaut E, Horreau C, Pouplard C, et al. Alcohol consumption and psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2013;27:30–35. doi:10.1111/jdv.12164
  • Stankewicz HA, Richards JR, Salen P. Alcohol related psychosis. StatPearls Publishing; 2002. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459134/. Accessed May 19, 2022.
  • Kimball AB, Wu EQ, Guérin A, et al. Risks of developing psychiatric disorders in pediatric patients with psoriasis. J Am Acad Dermatol. 2012;67(4):651–7.e1–2. doi:10.1016/j.jaad.2011.11.948
  • Wei HT, Lan WH, Hsu JW, et al. Risk of developing major depression and bipolar disorder among adolescents with atopic diseases: a nationwide longitudinal study in Taiwan. J Affect Disord. 2016;203:221–226. doi:10.1016/j.jad.2016.06.012
  • Tzeng NS, Chang HA, Chung CH, et al. Increased risk of psychiatric disorders in allergic diseases: a nationwide, population-based, cohort study. Front Psychiatry. 2018;9:133. doi:10.3389/fpsyt.2018.00133
  • Benros ME, Nielsen PR, Nordentoft M, Eaton WW, Dalton SO, Mortensen PB. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry. 2011;168(12):1303–1310. doi:10.1176/appi.ajp.2011.11030516
  • Ungprasert P, Wijarnpreecha K, Cheungpasitporn W. Patients with psoriasis have a higher risk of schizophrenia: a systematic review and meta-analysis of observational studies. J Postgrad Med. 2019;65(3):141–145. doi:10.4103/jpgm.JPGM_253_18
  • Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827–836. doi:10.1093/ije/dyv098
  • Abuabara P, Magyari AM, Hoffstad O, et al. Development and validation of an algorithm to accurately identify AE patients in primary care electronic health records from the UK. J Invest Dermatol. 2017;137:1655–1662. doi:10.1016/j.jid.2017.03.029
  • Seminara NM, Abuabara K, Shin DB, et al. Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol. 2011;164(3):602–609. doi:10.1111/j.1365-2133.2010.10134.x
  • Adesanya EI, Schonmann Y, Hayes JF, et al. Risk factors for mental illness in adults with atopic eczema or psoriasis: protocol for a systematic review. BMJ Open. 2020;10(12):e038324. doi:10.1136/bmjopen-2020-038324
  • Adesanya EI, Matthewman J, Schonmann Y, et al. Risk factors for depression, anxiety, and severe mental illness (SMI) in atopic eczema and psoriasis: a systematic review and meta-analysis. 2022.
  • Public Health Scotland. The Carstairs and Morris index. Available from: https://www.isdscotland.org/Products-and-services/Gpd-support/Deprivation/Carstairs/. Accessed June 15, 2022.
  • Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–1251. doi:10.1016/0895-4356(94)90129-5
  • Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. Wiley-Interscience; 2002.
  • Adesanya E. Code lists and do files for severe mental illness cohort study. Github; 2022. Available from: https://github.com/Elizabeth-jp/SMI-AEP-cohortstudy/tree/v1.0. Accessed August 1, 2022.
  • Mansfield KE, Schmidt SAJ, Darvalics B, et al. Association between atopic eczema and cancer in England and Denmark. JAMA Dermatol. 2020;156(10):1086–1097. doi:10.1001/jamadermatol.2020.1948
  • Parisi R, Rutter MK, Lunt M, et al. Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. J Invest Dermatol. 2015;135(9):2189–2197. doi:10.1038/jid.2015.87
  • Lapointe-Shaw L, Bouck Z, Howell NA, et al. Mediation analysis with a time-to-event outcome: a review of use and reporting in healthcare research. BMC Med Res Methodol. 2018;18(1):118. doi:10.1186/s12874-018-0578-7
  • Primary Care Strategy and NHS Contracts Group. 2019/20 General Medical Services (GMS) contract Quality and Outcomes Framework (QOF). 2019.
  • Vandenbroucke J, Pearce N. Point: incident exposures, prevalent exposures, and causal inference: does limiting studies to persons who are followed from first exposure onward damage epidemiology? Am J Epidemiol. 2015;182(10):826–833. doi:10.1093/aje/kwv225
  • Yu J, Attarian H, Zee P, Silverberg JI. Burden of sleep and fatigue in US adults with atopic dermatitis. Dermatitis. 2016;27(2):50–58. doi:10.1097/DER.0000000000000161
  • Kaskie RE, Graziano B, Ferrarelli F. Schizophrenia and sleep disorders: links, risks, and management challenges. Nat Sci Sleep. 2017;9:227–239. doi:10.2147/NSS.S121076
  • Schonmann Y, Mansfield KE, Hayes JF, et al. Atopic eczema in adulthood and risk of depression and anxiety: a population-based cohort study. J Allergy Clin Immunol Pract. 2020;8(1):248–257.e16. doi:10.1016/j.jaip.2019.08.030
  • Higashi K, Medic G, Littlewood KJ, Diez T, Granström O, Hert MD. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol. 2013;3(4):200–218. doi:10.1177/2045125312474019
  • National Institute for Health and Care Excellence. Eczema – atopic: management. Available from: https://cks.nice.org.uk/topics/eczema-atopic/management/. Accessed February 13, 2022.
  • National Institute for Health and Care Excellence. Psoriasis: assessment and management. Available from: https://www.nice.org.uk/guidance/cg153/chapter/1-Recommendations. Accessed February 13, 2022.
  • Wittchen HU, Mühlig S, Beesdo K. Mental disorders in primary care. Dialogues Clin Neurosci. 2003;5(2):115–128. doi:10.31887/DCNS.2003.5.2/huwittchen
  • Lamb RC, Matcham F, Turner MA, et al. Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting. Br J Dermatol. 2017;176(4):1028–1034. doi:10.1111/bjd.14833
  • Simpson P, Akinlade B, Ardeleanu M. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2017;376(11):1090–1091.
  • National Institute for Health and Care Excellence. Insomnia – management. Available from: https://cks.nice.org.uk/topics/insomnia/. Accessed June 15, 2022.